Evidence map›Paper›PMID 32507951›Full record

ArticleInternational ophthalmology2020

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases.

Maria Vadalà, Chiara Davì, Giuseppe Ingrassia Strano, Enrica Giuffrida, Barbara Scrivo, Nicasio Ventura, Massimo Castellucci, Salvatore Cillino, Calogero Cammà, Maria Cappello

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maria VadalàBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffrè 13, 90127, Palermo, Italy. maria.vadala@unipa.it.ORCID http://orcid.org/0000-0002-2726-698X
Chiara DavìBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffrè 13, 90127, Palermo, Italy.
Giuseppe Ingrassia StranoGastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy.
Enrica GiuffridaGastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy.
Barbara ScrivoGastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy.
Nicasio VenturaBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffrè 13, 90127, Palermo, Italy.
Massimo CastellucciBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffrè 13, 90127, Palermo, Italy.
Salvatore CillinoBiomedicine, Neuroscience and Advance Diagnostic (BIND) Department, Ophthalmology Institute, University of Palermo, Via Liborio Giuffrè 13, 90127, Palermo, Italy.
Calogero CammàGastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy.
Maria CappelloGastroenterology and Hepatology Section, ProMiSe Department, University of Palermo, Palermo, Italy.
University of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness.

methodsWe developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs.

results35 patients (36.5%) were selected for the ophthalmologic examination on the basis of a positive screening test. Ocular EIMs were detected in 29 of 35 patients (83%).

conclusionA specific questionnaire can be useful for non-ophthalmologist physicians in a real world setting in order to select patients to be addressed to an ophthalmological visit, creating an integrated multidisciplinary clinical team, to improve management of IBD in order to prevent disability and guarantee quality of life.

Indexed as

Inflammatory Bowel DiseasesOphthalmologistsHumansPilot ProjectsQuality of LifeSurveys and QuestionnairesBiologic drugsInflammatory bowel diseaseOcular extraintestinal manifestationQuestionnaire

Identifiers

PMID32507951
OpenAlexW3033919768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.